The next generation of metabolic medicine isn't a drug. It's an ecosystem.
Microbiome-restoring metabolic medicines, built from precision-fermented plants and grain matrices.
The GLP-1 era exposed an upstream restoration gap.
GLP-1 drugs activate one of the body's most important metabolic pathways. But metabolic disease is broader than one hormone receptor.
Patients still face GI tolerability issues, discontinuation, and weight regain after stopping.
The next generations of medicines will restore the gut ecosystem upstream of GLP-1.
A new therapeutic category.
- Probiotics.
- Single-target drugs.
- Receptor-first pharmacology.
- Multi-kingdom ecology.
- System-first medicine.
- Endogenous signaling.
Our biotechnology turns plant matrices into standardized metabolic medicines.
Optimal substrate design & activation.
Natural botanical substrates are conditioned through malting, hydration, milling, and thermal processing to create structured biological feedstock. First program: banana, millet, sorghum.
Precision ecological fermentation.
Bacteria, yeasts, and fungi are guided through controlled succession to convert the activated matrix into cross-feeding precursors which then create gut-relevant metabolites.
Clinical productization.
The payload is characterized, batch-tested, stabilized, and formulated as a physician-supervised metabolic intervention.
Four conditions have come into alignment.
GLP-1 created the market.
Massive demand for metabolic intervention — but tolerability, discontinuation, and weight regain remain unsolved.
Human testing can move faster.
Food-grade plant matrices allow early clinical learning with short-cycle metabolic readouts.
AI makes ecology engineerable.
Computational biology can now map substrates, microbial communities, metabolite fingerprints, and patient response.
Commercial entry is possible now.
Medical-food and physician-supervised pathways create early revenue while building the human dataset.
One platform. Multiple chronic disease markets.
Shared gut-axis biology enables capital-efficient expansion across indications.
A team built for ecological therapeutics.
Computational biology. Ecological fermentation. Clinical translation.